<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Enhanced anticancer effect of newly synthesised albumin-bound Fe(III)-S-Methyl-thiosemicarbazones on breast cancer cells

Loading...
Thumbnail Image

Institution Authors

Organizational Units

Organizational Units

Advisor

Editor

Journal Title

Journal ISSN

Volume Title

Type:

Publisher

Informa UK Limited

DOI

10.1080/16583655.2024.2375454

Abstract

Thiosemicarbazones and their analogues are of significant interest due to their antiviral, antibacterial and anticancer properties. Recent advancements in nanoparticle-based therapeutics have enabled targeted cancer cell treatment while minimizing harm to healthy cells. This study focused on encapsulating patented N(1)-R1-salicylidene-N(4)-R2-salicylidene-S-methylisothiosemicarbazone complexes into albumin nanocarriers, creating albumin-bound Fe(III)-S-methyl-thiosemicarbazone (ALB-FeTc) nanoparticles via a novel UV-C lamp-assisted method. The nanoparticles were characterized using FTIR, UV-Vis, DLS and EDX-SEM. Cytotoxicity was evaluated in MCF-7 breast cancer cells and HUVEC cells using an MTT assay. Fluorescence microscopy and flow cytometry were employed to investigate the mechanism of cell death. The study demonstrated strong cytotoxicity of FeTcs against cancer cells, with enhanced effects observed for ALB-FeTcs. The ALB-FeTcs induced apoptosis selectively in cancer cells while sparing normal cells. These results suggest that ALB-FeTcs are promising candidates for breast cancer treatment.

Description

Journal or Series

Journal of Taibah University for Science

ISSN

ISBN

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

info:eu-repo/semantics/openAccess

Research Projects

Journal Issue

Related Patent

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators